Female mice and rats displayed greater nausea-associated behaviors after receiving GLP-1 drugs, mirroring human data
This FDA-approved medication delivers impressive results, with patients losing an average of 10.9% of their total body weight in just 6 months
But the null finding is notable because it suggests that GLP-1 appetite suppression may already be near the ceiling of what appetite reduction can achieve, leaving little room for phentermine to add benefit
[18] Other research suggests that several pharmaceutical companies, including AstraZeneca, Zealand Pharma, Roche, and Amgen, are expected to enter the GLP-1 market, with multiple drug launches planned between 2027 and 2032
Constipation : Increase fiber intake through fruits, vegetables, and whole grains